Medical device manufacturer Neurovision Medical has won a $30 million intellectual property lawsuit in federal court against a rival start-up, NuVasive. The verdict was reached April 3 after a five-day trial in the US District Court for the Central District of California.
According to court documents, Neurovision Medical claimed that “years ago when NuVasive was a start up, it deliberately appropriated for itself the goodwill associated with Neurovision Medical’s established trademark.” Attorneys for Neurovision argued that NuVasive infringed upon their trademark for “Neurovision” and defrauded the US Patent and Trademark Office by registering the trademark for itself. The jury agreed that Neurovision Medical owns the Neurovision trademark throughout the United States.
Attorneys for Neurovision Medical were Peter Ross and Keith Wesley of Browne George Ross, LLP of Los Angeles. William Boggs of DLA Piper in Los Angeles represented NuVasive. The case is Neurovision Medical Products, Inc. v. NuVasive, Inc., Case Number: 2:09-cv-6988-DSF (JEMx).
